Interactions Between Anandamide and Corticotropin-Releasing Factor Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions

Biological Psychiatry

Volumn 80, Issue 5, 2016, Pages 356-362

  Demers, Catherine H ^a   Drabant Conley, Emily ^b   Bogdan, Ryan ^a   Hariri, Ahmad R ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b 23andMe Inc ^*  (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Amygdala; Anxiety; CRHR1; FAAH; Habituation; Imaging genetics

Indexed keywords

ANANDAMIDE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; GENOMIC DNA; AMIDASE; AMIDE; ARACHIDONIC ACID DERIVATIVE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; ENDOCANNABINOID; FATTY-ACID AMIDE HYDROLASE; OXYGEN;

ADULT; ANXIETY; ANXIETY DISORDER; ARTICLE; BASOLATERAL AMYGDALA; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GENETIC BACKGROUND; GENETIC POLYMORPHISM; GENOTYPE; HABITUATION; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; YOUNG ADULT; AMYGDALA; DIAGNOSTIC IMAGING; GENETICS; IMAGE PROCESSING; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AMIDOHYDROLASES; AMYGDALA; ANXIETY; ARACHIDONIC ACIDS; CORTICOTROPIN-RELEASING HORMONE; ENDOCANNABINOIDS; FEMALE; GENOTYPE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYUNSATURATED ALKAMIDES; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84975687538     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.12.021     Document Type: Article

References (46)

1. 1 Gunduz-Cinar, O., MacPherson, K.P., Cinar, R., Gamble-George, J., Sugden, K., Williams, B., et al. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry 18 (2013), 813–823.
2. 2 Hill, M.N., McLaughlin, R.J., Bingham, B., Shrestha, L., Lee, T.T.Y., Gray, J.M., et al. Endogenous cannabinoid signaling is essential for stress adaptation. Proc Natl Acad Sci U S A 107 (2010), 9406–9411.
3. 3 Hill, M.N., McLaughlin, R.J., Morrish, A.C., Viau, V., Floresco, S.B., Hillard, C.J., Gorzalka, B.B., Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology 34 (2009), 2733–2745.
4. 4 Gunduz-Cinar, O., Hill, M.N., McEwen, B.S., Holmes, A., Amygdala FAAH and anandamide: Mediating protection and recovery from stress. Trends Pharmacol Sci 34 (2013), 637–644.
5. 5 Haller, J., Barna, I., Barsvari, B., Gyimesi Pelczer, K., Yasar, S., Panlilio, L.V., Goldberg, S., Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. Psychopharmacology (Berl) 204 (2009), 607–616.
6. 6 Moreira, F.A., Kaiser, N., Monory, K., Lutz, B., Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 54 (2008), 141–150.
7. 7 Rademacher, D.J., Meier, S.E., Shi, L.Y., Ho, W.S.V., Jarrahian, A., Hillard, C.J., Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 54 (2008), 108–116.
8. 8 Patel, S., Roelke, C.T., Rademacher, D.J., Hillard, C.J., Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur J Neurosci 21 (2005), 1057–1069.
9. 9 Gray, J.M., Vecchiarelli, H.A., Morena, M., Lee, T.T., Hermanson, D.J., Kim, A.B., et al. Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. J Neurosci 35 (2015), 3879–3892.
10. 10 Sipe, J.C., Chiang, K., Gerber, A.L., Beutler, E., Cravatt, B.F., A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc Natl Acad Sci U S A 99 (2002), 8394–8399.
11. 11 Chiang, K.P., Gerber, A.L., Sipe, J.C., Cravatt, B.F., Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: Evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet 13 (2004), 2113–2119.
12. 12 Hariri, A.R., Gorka, A., Hyde, L.W., Kimak, M., Halder, I., Ducci, F., et al. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol Psychiatry 66 (2009), 9–16.
13. 13 Dincheva, I., Drysdale, A.T., Hartley, C.A., Johnson, D.C., Jing, D., King, E.C., et al. FAAH genetic variation enhances fronto-amygdala function in mouse and human. Nat Commun, 6, 2015, 6395.
14. 14 Tyrka, A.R., Price, L.H., Gelernter, J., Schepker, C., Anderson, G.M., Carpenter, L.L., Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: Effects on hypothalamic-pituitary-adrenal axis reactivity. Biol Psychiatry 66 (2009), 681–685.
15. 15 Heim, C., Bradley, B., Mletzko, T.C., Deveau, T.C., Musselman, D.L., Nemeroff, C.B., et al. Effect of childhood trauma on adult depression and neuroendocrine function: Sex-specific moderation by CRH receptor 1 gene. Front Behav Neurosci, 3, 2009, 41.
16. 16 Bradley, R.G., Binder, E.B., Epstein, M.P., Tang, Y., Nair, H.P., Liu, W., et al. Influence of child abuse on adult depression: Moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 65 (2008), 190–200.
17. 17 Cicchetti, D., Rogosch, F.A., Oshri, A., Interactive effects of corticotropin releasing hormone receptor 1, serotonin transporter linked polymorphic region, and child maltreatment on diurnal cortisol regulation and internalizing symptomatology. Dev Psychopathol 23 (2011), 1125–1138.
18. 18 Sumner, J.A., McLaughlin, K.A., Walsh, K., Sheridan, M.A., Koenen, K.C., CRHR1 genotype and history of maltreatment predict cortisol reactivity to stress in adolescents. Psychoneuroendocrinology 43 (2014), 71–80.
19. 19 Mahon, P.B., Zandi, P.P., Potash, J.B., Nestadt, G., Wand, G.S., Genetic association of FKBP5 and CRHR1 with cortisol response to acute psychosocial stress in healthy adults. Psychopharmacology (Berl) 227 (2013), 231–241.
20. 20 Ahs, F., Kragel, P.A., Zielinski, D.J., Brady, R., LaBar, K.S., Medial prefrontal pathways for the contextual regulation of extinguished fear in humans. Neuroimage 122 (2015), 262–271.
21. 21 LaBar, K.S., Gatenby, J.C., Gore, J.C., LeDoux, J.E., Phelps, E.A., Human amygdala activation during conditioned fear acquisition and extinction: A mixed-trial fMRI study. Neuron 20 (1998), 937–945.
22. 22 Green, S.A., Hernandez, L., Tottenham, N., Krasileva, K., Bookheimer, S.Y., Dapretto, M., Neurobiology of sensory overresponsivity in youth with autism spectrum disorders. JAMA Psychiatry 72 (2015), 778–786.
23. 23 Swartz, J.R., Wiggins, J.L., Carrasco, M., Lord, C., Monk, C.S., Amygdala habituation and prefrontal functional connectivity in youth with autism spectrum disorders. J Am Acad Child Adolesc Psychiatry 52 (2013), 84–93.
24. 24 Blackford, J.U., Allen, A.H., Cowan, R.L., Avery, S.N., Amygdala and hippocampus fail to habituate to faces in individuals with an inhibited temperament. Soc Cogn Affect Neurosci 8 (2013), 143–150.
25. 25 Milad, M.R., Pitman, R.K., Ellis, C.B., Gold, A.L., Shin, L.M., Lasko, N.B., et al. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry 66 (2009), 1075–1082.
26. 26 Gunduz-Cinar, O., Flynn, S., Brockway, E., Kaugars, K., Baldi, R., Ramikie, T.S., et al. Fluoxetine facilitates fear extinction through amygdala endocannabinoids. Neuropsychopharmacology 41 (2015), 1598–1609.
27. 27 Carey, C.E., Agrawal, A., Zhang, B., Conley, E.D., Degenhardt, L., Heath, A.C., et al. Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. J Abnorm Psychol 124 (2015), 860–877.
28. 28 Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:suppl 20 (1998), 22–33 quiz 34–57.
29. 29 First, M.B., Gibbon, M., Spitzer, R.L., Williams, JBW, Benjamin, L.S., Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). 1997, American Psychiatric Press, Inc., Washington DC.
30. 30 Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A., Reich, D., Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38 (2006), 904–909.
31. 31 Ahs, F., Davis, C.F., Gorka, A.X., Hariri, A.R., Feature-based representations of emotional facial expressions in the human amygdala. Soc Cogn Affect Neurosci 9 (2014), 1372–1378.
32. 32 Carre, J.M., Fisher, P.M., Manuck, S.B., Hariri, A.R., Interaction between trait anxiety and trait anger predict amygdala reactivity to angry facial expressions in men but not women. Soc Cogn Affect Neurosci 7 (2012), 213–221.
33. 33 Ekman, P, Friesen, WV, Constants across cultures in the face and emotion. J Pers Soc Psychol, 17, 1971, 124.
34. 34 Whitfield-Gabrieli, S., Artifact Detection and QA Manual. 2009, MIT Press, Cambridge, MA.
35. 35 Maldjian, J.A., Laurienti, P.J., Kraft, R.A., Burdette, J.H., An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19 (2003), 1233–1239.
36. 36 Amunts, K., Kedo, O., Kindler, M., Pieperhoff, P., Mohlberg, H., Shah, N.J., et al. Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: Intersubject variability and probability maps. Anat Embryol (Berl) 210 (2005), 343–352.
37. 37 Bogdan, R., Williamson, D.E., Hariri, A.R., Mineralocorticoid receptor Iso/Val (rs5522) genotype moderates the association between previous childhood emotional neglect and amygdala reactivity. Am J Psychiatry 169 (2012), 515–522.
38. 38 Nikolova, Y.S., Koenen, K.C., Galea, S., Wang, C.M., Seney, M.L., Sibille, E., et al. Beyond genotype: Serotonin transporter epigenetic modification predicts human brain function. Nat Neurosci 17 (2014), 1153–1155.
39. 39 Swartz, J.R., Knodt, A.R., Radtke, S.R., Hariri, A.R., A neural biomarker of psychological vulnerability to future life stress. Neuron 85 (2015), 505–511.
40. 40 Hayes, A.F., Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. 2013, Guilford Press, New York.
41. 41 Keller, M.C., Gene x environment interaction studies have not properly controlled for potential confounders: The problem and the (simple) solution. Biol Psychiatry 75 (2014), 18–24.
42. 42 Baas, D., Aleman, A., Kahn, R.S., Lateralization of amygdala activation: A systematic review of functional neuroimaging studies. Brain Res Brain Res Rev 45 (2004), 96–103.
43. 43 Stein, M.B., Simmons, A.N., Feinstein, J.S., Paulus, M.P., Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. Am J Psychiatry 164 (2007), 318–327.
44. 44 Hill, M.N., Bierer, L.M., Makotkine, I., Golier, J.A., Galea, S., McEwen, B.S., et al. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Psychoneuroendocrinology 38 (2013), 2952–2961.
45. 45 Gaetani, S., Dipasquale, P., Romano, A., Righetti, L., Cassano, T., Piomelli, D., Cuomo, V., The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs. Int Rev Neurobiol 85 (2009), 57–72.
46. 46 Hill, M.N., Gorzalka, B.B., The endocannabinoid system and the treatment of mood and anxiety disorders. CNS Neurol Disord Drug Targets 8 (2009), 451–458.